March Therapeutics
Biotechnology ResearchMassachusetts, United States2-10 Employees
March Therapeutics is a biotechnology research company focused on advancing genetic medicines. Its work centers on applying an evolutionary approach that combines molecular recording and advanced computing to identify and optimize novel protein modalities for therapeutic use, aiming to enhance the discovery and development process. The company serves researchers and developers in the biopharma space seeking innovative genetic medicine solutions, addressing challenges in discovering durable and effective protein-based therapies. Based in Cambridge, Massachusetts, the firm operates within the biotechnology research sector and emphasizes scientifically driven methods to mine natural diversity for therapeutic applications. The organization is small in size, reflecting its early-stage footprint in this specialized field, and recent developments include ongoing explorations into its Biomolecular Learning framework as a core avenue for its research activities.